The purpose of this Funding Opportunity Announcement (FOA) is to invite applications to support innovative research to improve our understanding of innate and adaptive immune dysregulation caused by Type 2 diabetes mellitus (DM) and pre-diabetes that causes increased risk of latent tuberculosis (TB)
re-activation and more severe active TB disease with more frequent treatment failure/relapse and death in the context of HIV co-infection.
Relevant Nonprofit Program Categories
Obtain Full Opportunity Text:http://grants.nih.gov/grants/guide/pa-files/PA-17-283.html
Additional Information of Eligibility:Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Asian American Native American Pacific Islander Serving Institutions (AANAPISISs); Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Non-domestic (non-U.S.) Entities (Foreign Organizations); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U. S. Territory or Possession.
Full Opportunity Web Address:http://grants.nih.gov/grants/guide/pa-files/PA-17-283.htmlContact: NIH OER WebmasterFBOWebmaster@OD.NIH.GOV
Agency Email Description: If you have any problems linking to this funding announcement, please contact the NIH OER Webmaster
Agency Email: FBOWebmaster@OD.NIH.GOV
Date Posted: 2017-05-12
Application Due Date: 2020-09-07
Archive Date: 2020-10-13